CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Updated UK guidance for finerenone introduces new treatment for HF patients

RegulatoryapprovedfinerenonePositive
AI Analysis

Summary

NICE has issued updated guidance in the UK providing a framework for healthcare providers to use finerenone for managing certain types of heart failure. The guidance establishes treatment protocols for HF patients.

Outcome Details

NICE guidance provided for finerenone in heart failure treatment

Importance:5/10
Sentiment:
0.60
regulatory approvalUK guidanceheart failureNICEfinerenone

Read the original article

Published by Pharmaceutical Technology on August 18, 2026 10:29 AM

Read Original